| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +129K | 79.4% | $0.78 | +$100K |
| Sells | 1 | -33.3K | 20.6% | $35.00 | -$1.17M |
| Net | 0 | +95.2K | 58.8% | -$1.07M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Chandler Robinson | Chief Executive Officer, Director | $37M | Mar 31, 2025 | ||
| Tactic Pharma LLC | 10%+ Owner | $28.8M | -$1.17M | -3.9% | Apr 2, 2025 |
| Andrew Cittadine | Chief Operating Officer | $2.67M | +$100K | +3.9% | Mar 31, 2025 |
| Lavina Talukdar | Director | $308K | Mar 4, 2025 | ||
| Michael J. Brown | Director | $137K | Dec 31, 2023 | ||
| Kim R. Tsuchimoto | Director | $96.4K | Mar 4, 2025 | ||
| Andrew Paul Mazar | Chief Scientific Officer, Director | $94.4K | Mar 31, 2022 | ||
| Karthik Radhakrishnan | Chief Financial Officer | $10.4K | Oct 28, 2024 | ||
| TacticGem LLC | 10%+ Owner | $0 | Dec 9, 2024 | ||
| Christopher M. Starr | Director | Mar 4, 2025 | |||
| Patrice Rioux | Acting Chief Medical Officer | Jan 1, 2025 | |||
| Raymond Anderson | Director | Mar 4, 2025 | |||
| Jose Octavio Filho | Chief Medical Officer | Jul 12, 2021 | |||
| Arthur J. Klausner | Director | Mar 4, 2025 | |||
| Quan Vu | Chief Financial Officer | Mar 3, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|